Low serum 1,5‐anhydroglucitol is associated with increased risk of all‐cause and cardiovascular mortality in type 2 diabetes: A real‐world cohort study
Study context
- Population
- Patients with T2D
- Participants
- 3,721 patients
- Outcome
- All-cause and cardiovascular mortality
- Follow-up
- median 7.4-year follow-up
Main finding
As reported in the abstract
All-cause mortality
Death events
528
Observational data: associations, not effects.
Further findings
CV mortality · median 7.4-year follow-up
- CV deaths
- 183
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Low serum 1,5‐anhydroglucitol is associated with increased risk of all‐cause and cardiovascular mortality in type 2 diabetes: A real‐world cohort study. Diabetes Obes Metab. Published 15 October 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →